1. Miller DL, Allen MS. Rare pulmonary neoplasms. Mayo Clin Proc. 1993; 68:492–498.
2. Yousem SA, Hochholzer L. Mucoepidermoid tumors of the lung. Cancer. 1987; 60:1346–1352.
3. Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009; 3:69–77.
4. Heitmiller RF, Mathisen DJ, Ferry JA, Mark EJ, Grillo HC. Mucoepidermoid lung tumors. Ann Thorac Surg. 1989; 47:394–399.
5. Vadasz P, Egervary M. Mucoepidermoid bronchial tumors: a review of 34 operated cases. Eur J Cardiothorac Surg. 2000; 17:566–569.
6. Chin CH, Huang CC, Lin MC, Chao TY, Liu SF. Prognostic factors of tracheobronchial mucoepidermoid carcinoma: 15 years experience. Respirology. 2008; 13:275–280.
7. Rossi G, Sartori G, Cavazza A, Tamberi S. Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and KRAS mutations, and differential diagnosis. Lung Cancer. 2009; 63:159–160.
8. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998; 82:1217–1224.
9. Song Z, Liu Z, Wang J, Zhu H, Zhang Y. Primary tracheobronchial mucoepidermoid carcinoma: a retrospective study of 32 patients. World J Surg Oncol. 2013; 11:62.
10. Ha SY, Han J, Lee JJ, Kim YE, Choi YL, Kim HK. Mucoepidermoid carcinoma of tracheobronchial tree: clinicopathological study of 31 cases. Korean J Pathol. 2011; 45:175–181.
11. Han SW, Kim HP, Jeon YK, Oh DY, Lee SH, Kim DW, et al. Mucoepidermoid carcinoma of lung: potential target of EGFRdirected treatment. Lung Cancer. 2008; 61:30–34.
12. Lee KW, Chan AB, Lo AW, Lam KC. Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma. J Thorac Oncol. 2011; 6:2140–2141.